Anson Funds Management LP Ensysce Biosciences, Inc. Transaction History

Anson Funds Management LP

  • $839 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$100.8 - $345.6 $174 Million - $596 Million
-1,724,703 Reduced 91.97%
150,664 $131,000
Q1 2022

May 12, 2022
BUY
$230.4 - $1140.0 $432 Million - $2.14 Billion
1,875,367 New
1,875,367 $2.14 Million

Others Institutions Holding ENSC

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About Ensysce Biosciences, Inc.

ENSC Quotes by TradingView
  • Ticker ENSC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,918,900
  • Market Cap $825K
  • Description
  • Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...
More about ENSC
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email